Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact. Through parallel integration with pre-clinical discovery, Wheeler is democratizing access to comprehensive discovery-to-IND programs with its rapid, high-quality biomanufacturing and Portable CMC™ platform. With an initial focus on antibody therapeutics, the company is partnered with Alloy Therapeutics to offer emerging biopharma companies a faster and more predictable path to the clinic by avoiding the critical gaps between discovery and early development. Wheeler's unique partnering model is built on shared success, creating a singular focus on quality, speed, and lasting collaborations.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/04/22 | $14,000,000 | Seed |
Alloy Therapeutics Echo Investment Capital Floating Point Presbyterian Health Foundation | undisclosed |
| 03/19/25 | $35,000,000 | Series A-1 |
Alloy Therapeutics Echo Investment Capital Germin8 Ventures Mitsubishi Corporation Russell Westbrook | undisclosed |
